Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jiashen Lifecare Investment Management, commonly known as Jiashen Capital, is a professional investment firm based in Shanghai, China, that specializes in the life sciences and healthcare sectors. The firm focuses on venture capital and private equity investments, targeting high-growth companies involved in biotechnology, innovative drug development, and medical devices. Jiashen Capital plays a strategic role in the Chinese healthcare market by providing essential funding and industry expertise to emerging medical enterprises. Its investment portfolio includes several prominent Chinese biotech firms, such as Genor Biopharma and Zhaoke Ophthalmology. By fostering innovation and supporting the commercialization of new medical technologies, the firm contributes significantly to the advancement of the healthcare ecosystem in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Jiashen Lifecare Investment Management.